|
BR0115772A
|
|
Processes for reducing or preventing eye transplant rejection and intraocular implants for use in transplantation
|
|
US6726918B1
|
|
Methods for treating inflammation-mediated conditions of the eye
|
|
EP1143935A2
|
|
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6369116B1
|
|
Composition and method for treating glaucoma
|
|
AU8522998A
|
|
Biocompatible ocular implants
|
|
US5869079A
|
|
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
CA2176145A1
|
|
Biocompatible ocular implants
|
|
WO9503009A1
|
|
Method of treatment of macular degeneration
|
|
US5443505A
|
|
Biocompatible ocular implants
|
